Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00554268 · ClinicalTrials.gov registry record · Phase 1
Trial of PBI-05204 in Advanced Cancer Patients
A Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 58
- Enrollment target
NCT00554268: Completed Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT00554268 is a Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 58 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00554268, a Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 58 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to find the highest safe dose of PBI-05204 that can be given to patients with advanced solid tumors. The study will also look at how PBI-05204 is processed by the body, how it leaves the body, how it affects the body, and if it is affecting certain proteins in the cancer cells.
Interventions
- DRUG PBI-05204
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2007-10 |
| Est. Completion | 2013-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00554268
The ClinicalTrials.gov registry entry for NCT00554268 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PBI-05204 is the first listed.
NCT00554268 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00554268 about?
NCT00554268 is a clinical study titled "Trial of PBI-05204 in Advanced Cancer Patients". The goal of this clinical research study is to find the highest safe dose of PBI-05204 that can be given to patients with advanced solid tumors. The study will also look at how PBI-05204 is processed by the body, how it leaves the body, how it affects the body, and if it is affecting certain protein...
What is the current status of trial NCT00554268?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 58 participants. The study started on 2007-10. Estimated completion is 2013-04.
What interventions are being tested in trial NCT00554268?
The interventions under investigation include: PBI-05204 (DRUG).
Who is sponsoring clinical trial NCT00554268?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.